Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Odonate Therapeutics, Inc.
Scientific Title
Multinational, Multicenter, Phase 2 Study of Tesetaxel Plus a Reduced Dose of Capecitabine in Patients With HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer Who Have Not Previously Received a Taxane